Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3527325
Max Phase: Preclinical
Molecular Formula: C28H27Cl2FN2O7S
Molecular Weight: 625.50
Molecule Type: Small molecule
Associated Items:
ID: ALA3527325
Max Phase: Preclinical
Molecular Formula: C28H27Cl2FN2O7S
Molecular Weight: 625.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)NC(=O)c1ccc(Oc2cc(F)c(CC(=O)O)cc2Cl)c(NS(=O)(=O)c2ccc(C3(O)CC3)cc2Cl)c1
Standard InChI: InChI=1S/C28H27Cl2FN2O7S/c1-27(2,3)32-26(36)15-4-6-22(40-23-14-20(31)16(10-18(23)29)12-25(34)35)21(11-15)33-41(38,39)24-7-5-17(13-19(24)30)28(37)8-9-28/h4-7,10-11,13-14,33,37H,8-9,12H2,1-3H3,(H,32,36)(H,34,35)
Standard InChI Key: NBKJFYDDZXLIQP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 625.50 | Molecular Weight (Monoisotopic): 624.0900 | AlogP: 5.86 | #Rotatable Bonds: 9 |
Polar Surface Area: 142.03 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.11 | CX Basic pKa: | CX LogP: 4.70 | CX LogD: 0.52 |
Aromatic Rings: 3 | Heavy Atoms: 41 | QED Weighted: 0.23 | Np Likeness Score: -1.20 |
1. Foti RS, Pearson JT, Wong SL, Zalikowski JA, Boudreaux MD, Prokop SP, Davis JA, Banfield C, Emery MG, Rock DA, Wahlstrom JL, Wienkers LC, Amore BM.. (2012) Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptors., 40 (12): [PMID:22930276] [10.1124/dmd.112.047928] |
Source(1):